AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.33
-0.26 (-2.46%)
Feb 21, 2025, 4:00 PM EST - Market closed
AngioDynamics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 13, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 25.85% from the current stock price of 10.33.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 10, 2025.
Analyst Ratings
The average analyst rating for AngioDynamics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +45.21% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +35.53% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +35.53% | Oct 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +16.17% | Oct 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +35.53% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
290.61M
from 303.91M
Decreased by -4.38%
Revenue Next Year
309.88M
from 290.61M
Increased by 6.63%
EPS This Year
-0.38
from -4.59
EPS Next Year
-0.22
from -0.38
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 300.2M | 324.4M | 343.2M | ||
| Avg | 290.6M | 309.9M | 333.3M | ||
| Low | 277.8M | 294.5M | 320.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.2% | 11.6% | 10.7% | ||
| Avg | -4.4% | 6.6% | 7.6% | ||
| Low | -8.6% | 1.3% | 3.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.37 | -0.15 | 0.09 | ||
| Avg | -0.38 | -0.22 | 0.09 | ||
| Low | -0.37 | -0.29 | 0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.